Description
The RoC® MULTI CORREXION® line contains breakthrough products that diminish the appearance of multiple signs of aging with the exclusive fusion of pure RoC® RETINOL and antioxidants. RoC® MULTI CORREXION® Night Treatment provides a comprehensive anti-aging solution to diminish the look of the most noticeable signs of aging and reveal new, younger looking skin. RESULTS: In just 4 weeks, dark circles are visibly diminished and skin tone and luminescence are noticeably improved. In just 8 weeks, the appearance of pores and skin discolorations are visibly diminished. In just 12 weeks, the look of fine lines and wrinkles is visibly diminished. Skin firmness and elasticity are also improved. The result – overall younger-looking, more beautiful skin. USE: Apply to face and neck after cleansing. The treatment can be used alone or under your regular moisturizer. For best results, use twice daily. You may experience mild tingling or redness during use. This is normal and should be temporary until your skin adjusts. If applying an additional moisturizer, use one free of Retinol.
Ingredients
•Pure RoC® RETINOL smoothes wrinkles and complements skin's natural process •Antioxidants help defend against the look of aging •Vitamin C helps rejuvenate skin tone INGREDIENT LIST Water Isononyl Isononanoate Glycerin Steareth-2 Ascorbic Acid Dimethicone Cetyl Palmitate PEG-8 Sorbitan Stearate Butylene Glycol Cetyl Alcohol Steareth-21 Cyclopentasiloxane Retinol Copper Gluconate Magnesium Aspartate Zinc Gluconate Panthenol Butyrospermum Parkii (Shea Butter) Caprylyl Glycol Methylparaben Acrylates/C10-30 Alkyl Acrylate Crosspolymer Bisabolol Fragrance Disodium EDTA Propylparaben Xanthan Gum Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer Sucrose Cocoate Squalane BHT Tocopherol Polysorbate 20 Chlorhexidine Digluconate Polysorbate 60 Lactoferrin May also contain: Sodium Hydroxide
Find the best deals
- N/A RoC http://www.rocskincare.com
Sending...
This product was successfully sent to your friend!
There was an error, please try later...
Facebook
Twitter
Ask a question or leave a comment
0 comments